GSK ready to market Amgen’s new bone drug
Fresh off European approval of Amgen’s ( NASDAQ: AMGN ) much-anticipated bone drug Prolia (denosumab), GlaxoSmithKline ( NYSE: GSK ) will be gearing up to collaborate with
Related tweets from Twitter:
moody2728 : (????)? RT @kankunkazra: I'm at Gahana Fitness & Health Center, Kedaton w/ @moody2728 http://t.co/0OSvMR1d2012-02-12T09:19:13Z - Reply - View Tweet
PragProgForum : How the hell would he know?--Dave.... http://t.co/Ws2KFuW22012-02-12T03:52:00Z - Reply - View Tweet
JesseMixMan : RT @ohkeepahblog: News like this makes me so thankful for Phish's health.... that could've been Trey.2012-02-12T02:24:24Z - Reply - View Tweet- PragProgForum : Republicans Introduce Legislation That Allows Any Employer To Deny Any Preventive Health Service http://t.co/l3UODPfJ2012-02-11T21:57:31Z - Reply - View Tweet
WizeBarry : App Reviews: Fitness and Health Apps http://t.co/7YuICVP92012-02-11T21:20:12Z - Reply - View Tweet
Add this post to your favorites social bookmark
